Literature DB >> 23998793

Symptomatic hyperammonemia after lung transplantation: lessons learnt.

Siddiq Anwar1, Diptesh Gupta, Muhammad A Ashraf, Syed A Khalid, Syed M Rizvi, Brent W Miller, Daniel C Brennan.   

Abstract

Hyperammonemia, post-orthotopic lung transplantation, is a rare but mostly fatal complication. Various therapies, including those to decrease ammonia generation, increase nitrogen excretion, and several dialytic methods for removing ammonia have been tried. We describe three lung transplant recipients who developed acute hyperammonemia early after transplantation. Two of the three patients survived after a multidisciplinary approach including discontinuation of drugs, which impair urea cycle, aggressive ammonia reduction with prolonged daily intermittent hemodialysis (HD), and overnight slow low-efficiency dialysis in conjunction with early weaning of steroids and other therapeutic measures. Our experience suggests that early initiation of dialysis, high dialysis dose, increased frequency, and HD preferably to less efficient modalities increases survival in these patients.
© 2013 International Society for Hemodialysis.

Entities:  

Keywords:  Hyperammonemia; dialysis; lung transplantation; renal replacement therapy

Mesh:

Year:  2013        PMID: 23998793     DOI: 10.1111/hdi.12088

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  14 in total

1.  Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans.

Authors:  Ankit Bharat; Scott A Cunningham; G R Scott Budinger; Daniel Kreisel; Charl J DeWet; Andrew E Gelman; Ken Waites; Donna Crabb; Li Xiao; Sangeeta Bhorade; Namasivayam Ambalavanan; Daniel F Dilling; Erin M Lowery; Todd Astor; Ramsey Hachem; Alexander S Krupnick; Malcolm M DeCamp; Michael G Ison; Robin Patel
Journal:  Sci Transl Med       Date:  2015-04-22       Impact factor: 17.956

2.  Ureaplasma parvum causes hyperammonemia in a pharmacologically immunocompromised murine model.

Authors:  X Wang; K E Greenwood-Quaintance; M J Karau; D R Block; J N Mandrekar; S A Cunningham; J M Mallea; R Patel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-28       Impact factor: 3.267

3.  Features of Adult Hyperammonemia Not Due to Liver Failure in the ICU.

Authors:  Amra Sakusic; Moldovan Sabov; Amanda J McCambridge; Alejandro A Rabinstein; Tarun D Singh; Kumar Mukesh; Kianoush B Kashani; David Cook; Ognjen Gajic
Journal:  Crit Care Med       Date:  2018-09       Impact factor: 7.598

Review 4.  The Evolution of Lung Transplant Immunosuppression.

Authors:  Steven Ivulich; Glen Westall; Michael Dooley; Gregory Snell
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

5.  Impact of Screening and Treatment of Ureaplasma species on Hyperammonemia Syndrome in Lung Transplant Recipients: A Single Center Experience.

Authors:  Scott C Roberts; Ankit Bharat; Chitaru Kurihara; Rade Tomic; Michael G Ison
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

Review 6.  Hyperammonemia in lung transplant patients and its management: a review.

Authors:  Akshay Kumar; Shailesh Advani; Kichloo Asim; Mohamed A Mohamed; Farah Wani; Jagmeet Singh; Michael Albosta; Nimisha Shiwalkar; Suresh Keshavamurthy
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-03-14

Review 7.  Hyperammonemia syndrome in immunosuppressed individuals.

Authors:  Scott C Roberts; Waleed Malik; Michael G Ison
Journal:  Curr Opin Infect Dis       Date:  2022-06-01       Impact factor: 4.968

Review 8.  The Role of RRT in Hyperammonemic Patients.

Authors:  Shruti Gupta; Andrew Z Fenves; Robert Hootkins
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

Review 9.  An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant Recipients.

Authors:  O C Smibert; M A Paraskeva; G Westall; Greg Snell
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

10.  Ureaplasma urealyticum Causes Hyperammonemia in an Experimental Immunocompromised Murine Model.

Authors:  Xiaohui Wang; Melissa J Karau; Kerryl E Greenwood-Quaintance; Darci R Block; Jayawant N Mandrekar; Scott A Cunningham; Robin Patel
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.